Inhibition of inducible nitric oxide synthase promotes vein graft neoadventitial inflammation and remodelling

Journal of Vascular Research

Volumn 48, Issue 2, 2011, Pages 141-149

  Wu, Junxi ^a   Wadsworth, Roger M ^a   Kennedy, Simon ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adventitia; Endothelium; Inducible nitric oxide synthase; Neointima; Nitric oxide; Vascular function; Vein graft

Indexed keywords

ENDOTHELIN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CAVA VEIN; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GRAFT PATENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REENDOTHELIALIZATION; REVASCULARIZATION; UPREGULATION; VASCULAR DISEASE; VEIN GRAFT; VEIN GRAFT NEOADVENTITIAL INFLAMMATION; VEIN GRAFT REMODELLING;

ANIMALS; CAROTID ARTERIES; CONNECTIVE TISSUE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; IMINES; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; TRANSPLANTS; TUNICA INTIMA; UP-REGULATION; VASCULAR GRAFTING; VENA CAVA, INFERIOR;

EID: 77957744695     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316968     Document Type: Article

References (33)

1. Mills JL Sr, Wixon CL, James DC, Devine J, Westerband A, Hughes JD: The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg 2001; 33: 273-278; discussion 278-280.
2. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q: Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998; 153: 1301-1310. (Pubitemid 28465854)
3. Zhang L, Hagen PO, Kisslo J, Peppel K, Freedman NJ: Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. J Vasc Surg 2002; 36: 824-832. (Pubitemid 41122983)
4. Ohno N, Itoh H, Ikeda T, Ueyama K, Yamahara K, Doi K, Yamashita J, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Sakaguchi S, Sone M, Yurugi T, Kook H, Komeda M, Nakao K: Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of c-type natriuretic peptide. Circulation 2002; 105: 1623-1626. (Pubitemid 34298601)
5. Fulton GJ, Davies MG, Barber L, Gray JL, Svendsen E, Hagen PO: Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts. Eur J Vasc Endovasc Surg 1998; 15: 279-289. (Pubitemid 28205985)
6. Kown MH, Yamaguchi A, Jahncke CL, Miniati D, Murata S, Grunenfelder J, Koransky ML, Rothbard JB, Robbins RC: L -arginine polymers inhibit the development of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg 2001; 121: 971-980.
7. Wu S, Wang X, Guo L, Zi J: Adenovirus mediated endothelial nitric oxide synthase gene transfer prevents restenosis of vein grafts. Asaio J 2004; 50: 272-277. (Pubitemid 38608115)
8. Barbato JE, Tzeng E: Inos gene transfer for graft disease. Trends Cardiovasc Med 2004; 14: 267-272. (Pubitemid 39473305)
9. Channon KM, Fulton GJ, Gray JL, Annex BH, Shetty GA, Blazing MA, Peters KG, Hagen PO, George SE: Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels. Cardiovasc Res 1997; 35: 505-513. (Pubitemid 27469412)
10. Landis ME, Ray EC, Gloviczki P, Miller VM: Effects of dietary L -arginine on structure and function of flow-restricted vein grafts. J Vasc Surg 2001; 33: 829-839. (Pubitemid 33586639)
11. Yoon JH, Wu CJ, Homme J, Tuch RJ, Wolff RG, Topol EJ, Lincoff AM: Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model. Yonsei Med J 2002; 43: 242-251. (Pubitemid 34498428)
12. Mayr U, Zou Y, Zhang Z, Dietrich H, Hu Y, Xu Q: Accelerated arteriosclerosis of vein grafts in inducible no synthase(-/-) mice is related to decreased endothelial progenitor cell repair. Circ Res 2006; 98: 412-420.
13. Dattilo JB, Dattilo MP, Spratt JA, Matsuura J, Yager DR, Makhoul RG: Inducible nitric oxide synthase expression in human vein grafts. Am J Surg 1997; 174: 177-180. (Pubitemid 27383283)
14. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG: 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997; 272: 4959-4963. (Pubitemid 27090046)
15. Moore ZW, Hui DY: Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase. J Lipid Res 2005; 46: 2083-2090. (Pubitemid 41377460)
16. Guo JS, Cho CH, Wang JY, Koo MW: Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. Eur J Pharmacol 2006; 536: 301-308.
17. Sakaguchi Y, Shirahase H, Ichikawa A, Kanda M, Nozaki Y, Uehara Y: Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice. Life Sci 2004; 75: 2257-2267. (Pubitemid 39180035)
18. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26. (Pubitemid 8132079)
19. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM: Application of Photoshopbased image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997; 45: 1559-1565. (Pubitemid 27465476)
20. Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC, Mills JL, Hunter GC, Heimark RL: Vein adaptation to arterialization in an experimental model. J Vasc Surg 2001; 33: 561-569. (Pubitemid 32215607)
21. Ehsan A, Mann MJ, Dell'Acqua G, Tamura K, Braun-Dullaeus R, Dzau VJ: Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 2002; 105: 1686-1692. (Pubitemid 34298613)
22. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, Wiegand SJ, Fuster V, Badimon JJ, Sauter BV: Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004; 110: 2430-2435. (Pubitemid 39407350)
23. Kim MR, Jeon ES, Kim YM, Lee JS, Kim JH: Thromboxane A 2 induces differentiation of human mesenchymal stem cells to smooth muscle-like cells. Stem Cells 2009; 27: 191-199.
24. Fries DM, Paxinou E, Themistocleous M, Swanberg E, Griendling KK, Salvemini D, Slot JW, Heijnen HF, Hazen SL, Ischiropoulos H: Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem 2003; 278: 22901-22907. (Pubitemid 36830354)
25. Kleinert H, Pautz A, Linker K, Schwarz PM: Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004; 500: 255-266. (Pubitemid 39304013)
26. Yan Z, Hansson GK: Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 1998; 82: 21-29. (Pubitemid 28074015)
27. Chester AH, Morrison KJ, Yacoub MH: Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thorac Surg 1998; 65: 1685-1689.
28. Fuchs S, Kornowski R, Leon MB, Epstein SE: Anti-angiogenesis: a new potential strategy to inhibit restenosis. Int J Cardiovasc Intervent 2001; 4: 3-6. (Pubitemid 32799320)
29. Westerband A, Gentile AT, Hunter GC, Gooden MA, Aguirre ML, Berman SS, Mills JL: Intimal growth and neovascularization in human stenotic vein grafts. J Am Coll Surg 2000; 191: 264-271.
30. Khurana R, Simons M, Martin JF, Zachary IC: Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005; 112: 1813-1824. (Pubitemid 41368158)
31. Kwon HM, Sangiorgi G, Ritman EL, Mc-Kenna C, Holmes DR Jr, Schwartz RS, Lerman A: Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998; 101: 1551-1556. (Pubitemid 28198482)
32. Hatakeyama T, Pappas PJ, Hobson RW 2nd, Boric MP, Sessa WC, Duran WN: Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol 2006; 574: 275-281. (Pubitemid 43905811)
33. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001; 98: 2604-2609. (Pubitemid 32209529)